AbCellera Biologics Inc (NASDAQ:ABCL) has a beta value of 0.61 and has seen 8.06 million shares traded in the last trading session. The company, currently
During the last session, AbCellera Biologics Inc (NASDAQ:ABCL)’s traded shares were 6.97 million, with the beta value of the company hitting 0.61. At the end
In the last trading session, 1.95 million shares of the AbCellera Biologics Inc (NASDAQ:ABCL) were traded, and its beta was 0.61. Most recently the company’s
In the last trading session, 8.43 million AbCellera Biologics Inc (NASDAQ:ABCL) shares changed hands as the company’s beta touched 0.61. With the company’s per share
In last trading session, AbCellera Biologics Inc (NASDAQ:ABCL) saw 9.92 million shares changing hands with its beta currently measuring 0.52. Company’s recent per share price
AbCellera Biologics Inc (NASDAQ:ABCL) has a beta value of -61.25% and has seen 4.78 shares traded in the last trading session. The company, currently valued
In today’s recent session, 1.94 million shares of the AbCellera Biologics Inc (NASDAQ:ABCL) have been traded, and its beta is 0.37. Most recently the company’s
In the last trading session, 17.47 million AbCellera Biologics Inc (NASDAQ:ABCL) shares changed hands as the company’s beta touched 0.38. With the company’s per share
AbCellera Biologics Inc (NASDAQ:ABCL) has a beta value of 0.35 and has seen 1.08 million shares traded in the recent trading session. The company, currently
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne